Sankala Group
LLY icon

Sankala Group’s Eli Lilly LLY Stock Holding History

Sankala Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$143K Hold
123
– – 0.09% 166
2026
Q2 		$150K Sell
123
-6
-5% -$6.13K 0.1% 161
2026
Q1 		$115K Hold
129
– – 0.09% 167
2025
Q4 		$136K Buy
+129
New +$123K 0.11% 151

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Sankala Group's LLY Position: Q3 2026 in Review

Sankala Group held its Eli Lilly (LLY) position steady in Q3 2026 at 123 shares worth $143K. The position accounts for 0.09% of the portfolio, ranked #166.

Sankala Group first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $150K in Q2 2026. 2,975 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Sankala Group held 123 shares of Eli Lilly worth $143K as of Q3 2026.
  • Sankala Group left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.09% of Sankala Group's portfolio in Q3 2026, its #166 holding.
  • Sankala Group first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Sankala Group's Eli Lilly position peaked at $150K in Q2 2026.
  • 2,975 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Sankala Group's 13F filing for Q3 2026, filed 9 Nov 2026.